Epidermolysis bullosa simplex
Clinical trials for Epidermolysis bullosa simplex explained in plain language.
Never miss a new study
Get alerted when new Epidermolysis bullosa simplex trials appear
Sign up with your email to follow new studies for Epidermolysis bullosa simplex, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cream aims to soothe butterfly skin in Late-Stage trial
Symptom relief Not yet recruitingThis Phase 3 study tests the safety of SD-101 cream (6% allantoin) in 80 people with epidermolysis bullosa, a condition that causes fragile, blistering skin. Participants must have completed a prior study (SD-007). The main goal is to track any side effects over time.
Matched conditions: EPIDERMOLYSIS BULLOSA SIMPLEX
Phase 3 • Sponsor: Paradigm Therapeutics • Aim: Symptom relief
Last updated Sep 10, 2026 06:00 UTC
-
Can a birch bark gel soothe blistering skin disease?
Symptom relief Not yet recruitingThis pilot trial is testing whether a topical gel called Filsuvez, made from birch triterpenes, is safe and helpful for people aged 6 months and older with moderate-to-severe epidermolysis bullosa simplex (EBS), a condition causing fragile skin and blisters. Participants will app…
Matched conditions: EPIDERMOLYSIS BULLOSA SIMPLEX
Phase 2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC